Innovation at Penn
Browse Penn-owned technologies available for licensing.
Search Results - christopher hunter
Novel biologics to treat T cell mediated inflammatory disease
Biologic therapeutic approach to modulating T cell inflammatory diseases by expressing isolated or recombinant combinations of WSX-1 or gp130 polypeptide with interacting proteins (such as p28, EBI3, Il-27) to inhibit pathological T cell development. Problem: The interleukin-27 receptor (WSX -1) is a heterodimeric type I cytokine receptor for...
Therapeutics & Vaccines
© 2020. All Rights Reserved. Powered by